164 related articles for article (PubMed ID: 28375986)
1. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
Dominguez PM; Teater M; Shaknovich R
Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
[TBL] [Abstract][Full Text] [Related]
2. The many layers of epigenetic dysfunction in B-cell lymphomas.
Jiang Y; Dominguez PM; Melnick AM
Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
[TBL] [Abstract][Full Text] [Related]
3. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis.
Teater M; Dominguez PM; Redmond D; Chen Z; Ennishi D; Scott DW; Cimmino L; Ghione P; Chaudhuri J; Gascoyne RD; Aifantis I; Inghirami G; Elemento O; Melnick A; Shaknovich R
Nat Commun; 2018 Jan; 9(1):222. PubMed ID: 29335468
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of germinal center-derived B cell lymphomas.
Pasqualucci L
Immunol Rev; 2019 Mar; 288(1):240-261. PubMed ID: 30874347
[TBL] [Abstract][Full Text] [Related]
5. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Matsuda I; Imai Y; Hirota S
J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
[TBL] [Abstract][Full Text] [Related]
6. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
7. Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Waibel M; Gregory G; Shortt J; Johnstone RW
Curr Opin Hematol; 2014 Jul; 21(4):297-308. PubMed ID: 24811162
[TBL] [Abstract][Full Text] [Related]
8. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract][Full Text] [Related]
9. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
Bogusz AM; Bagg A
Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas.
Walsh SH; Grabowski P; Berglund M; Thunberg U; Thorsélius M; Tobin G; Aleskog A; Karlsson K; Sundström C; Laurell A; Enblad G; Rosenquist R; Roos G
Eur J Haematol; 2007 Apr; 78(4):283-9. PubMed ID: 17286609
[TBL] [Abstract][Full Text] [Related]
11. LymphomiRs: microRNAs with regulatory roles in lymphomas.
Kozloski GA; Lossos IS
Curr Opin Hematol; 2015 Jul; 22(4):362-8. PubMed ID: 26049758
[TBL] [Abstract][Full Text] [Related]
12. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis.
Kondo E; Yoshino T
Pathol Int; 2007 Jul; 57(7):391-7. PubMed ID: 17587238
[TBL] [Abstract][Full Text] [Related]
13. Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity.
De S; Shaknovich R; Riester M; Elemento O; Geng H; Kormaksson M; Jiang Y; Woolcock B; Johnson N; Polo JM; Cerchietti L; Gascoyne RD; Melnick A; Michor F
PLoS Genet; 2013; 9(1):e1003137. PubMed ID: 23326238
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers.
Wang MX; Wang HY; Zhao X; Srilatha N; Zheng D; Shi H; Ning J; Duff DJ; Taylor KH; Gruner BA; Caldwell CW
Int J Clin Exp Pathol; 2010 Jan; 3(3):265-79. PubMed ID: 20224725
[TBL] [Abstract][Full Text] [Related]
16. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic basis of diffuse large B-cell lymphoma.
Jiang Y; Melnick A
Semin Hematol; 2015 Apr; 52(2):86-96. PubMed ID: 25805588
[TBL] [Abstract][Full Text] [Related]
18. DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID.
Dominguez PM; Teater M; Chambwe N; Kormaksson M; Redmond D; Ishii J; Vuong B; Chaudhuri J; Melnick A; Vasanthakumar A; Godley LA; Papavasiliou FN; Elemento O; Shaknovich R
Cell Rep; 2015 Sep; 12(12):2086-98. PubMed ID: 26365193
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic determinants of B-cell lymphoma evolution.
Izzo F; Landau DA
Curr Opin Hematol; 2016 Jul; 23(4):392-401. PubMed ID: 27135978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
